PP
Phio Pharmaceuticals Corp
🇺🇸XNAS.PHIOUnited StatesHealthcare
$1.00USDdown -0.02 (-1.96%)ClosedDelayed5:02 AM
Price$1.00-0.02 (-1.96%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US71880W5013
- CUSIP
- 74979C105
Company
- Employees
- 6
- Headquarters
- King of Prussia, United States
- Website
- https://phiopharma.com
- CEO
- Mr. Robert J. Bitterman
Market
- Shares outstanding
- 11.6M
- Market cap
- $11.62M
Highlights
- Market cap
- $11.62M
- EPS LTM
- -$1.11calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.90calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$12.9M-82.13%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$12.21M-70.87%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.